BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Anthera Pharmaceuticals Announces Completion of Recruitment in the Phase III RESULT Clinical Study of Sollpura

  The RESULT study allows for more frequent and higher dose adjustments based upon clinical signs and symptoms than the previous Phase 3 SOLUTION study.

  November 9, 2017

   · 

  2 min read
• 

  Drug Development

  What a Turnaround: Otonomy Explodes as Lead Drug Succeeds in Late-Stage Study

  The company plans to meet with FDA to discuss results and clinical requirements for registration.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Job Trends

  After $40M Financing, Exonics Therapeutics to Start Hiring for Cambridge Lab

  The cash will allow the company to hire scientists to conduct preclinical research into a potential treatment for DMD.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Job Trends

  Sangamo Inks Deal for New HQ in Bay Area Biotech Hub

  Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA.

  November 9, 2017

   · 

  2 min read

   · 

  Mark Terry
• Business

  Xtant Medical Postpones Release of Third Quarter 2017 Financial Results

  The Company now plans to release its third quarter 2017 financial results in conjunction with the filing of its 10-Q which is currently expected to occur by November 20, 2017.

  November 9, 2017

   · 

  1 min read
• 

  FDA

  FDA Green Lights Neusoft Medical’s NeuViz Prime CT Scanner

  The latest advance in more than 20 years of continual CT innovation.

  November 9, 2017

   · 

  2 min read
• Business

  BioLineRx to Report Third Quarter 2017 Results on November 21, 2017

  Management to hold a conference call at 10:00 a.m. ET.

  November 9, 2017

   · 

  3 min read
• Business

  Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update

  Cash, cash equivalents and investments as of September 30, 2017, totaled $207.1 million as compared to $103.4 million as of June 30, 2017.

  November 9, 2017

   · 

  8 min read
• Novocure Announces 10 Presentations on Simulation Studies Aiming to Optimize Treatment Delivery of Tumor Treating Fields at 22nd Annual Meeting of the Society for Neuro-Oncology

  The 10 presentations include data on a new array layout that could allow delivery of TTFields to infra-tentorial brain tumors, and data showing correlation between TTFields intensity within and surrounding patients’ tumors and their clinical outcomes.

  November 9, 2017

   · 

  5 min read
• 

  Policy

  FDA Accepts Otsuka’s Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of ADPKD

  The FDA considers the resubmission to be filed as of October 24, 2017, with a PDUFA action date of April 24, 2018.

  November 9, 2017

   · 

  4 min read